Search clinical trials for: Bacillus Calmette-Guerin: Strain Russian BCG-I
Total 82 results
-
AerasSanofi Pasteur, a Sanofi CompanyCompleted
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-Muscle Invasive Bladder Cancer (NMIBC)United States
-
UNICANCERHoffmann-La RocheActive, not recruitingBladder CancerSpain, France, Belgium
-
Bristol-Myers SquibbTerminatedUrinary Bladder NeoplasmsUnited States, Netherlands, Italy, Argentina, Australia, Austria, Brazil, Canada, Chile, France, Germany, Greece, Israel, Japan, Russian Federation, Spain, Sweden
-
S. Andrea HospitalRecruitingMultiple SclerosisItaly
-
S. Andrea HospitalIstituto Superiore di Sanità; Italian Multiple Sclerosis FoundationCompleted
-
Fujian Medical University Union HospitalRecruitingUrinary Bladder Neoplasms | Treatment Outcome | Neoplasm Recurrence, Local | Multicenter Study | Immunotherapy, Active | BCG VaccineChina
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruiting
-
National University Hospital, SingaporeNational Medical Research Council (NMRC), SingaporeCompletedCarcinoma of Urinary Bladder, SuperficialSingapore
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Recruiting
-
University of SydneyAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Cancer...Active, not recruitingBladder CancerAustralia, United Kingdom
-
Bristol-Myers SquibbTerminatedUrinary Bladder NeoplasmsUnited States, Argentina, Australia, Brazil, Canada, Chile, China, France, Mexico, Netherlands, Spain, United Kingdom, Italy, Hong Kong, Russian Federation
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene CorporationCompleted
-
Bandim Health ProjectStatens Serum InstitutCompleted
-
Hoffmann-La RocheTerminated
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; New York Presbyterian HospitalTerminated
-
Assiut UniversityNot yet recruitingUrothelial Carcinoma Bladder | Sperm Count, Low | Testis; Fibrosis
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCCompletedRecurrent Bladder Carcinoma | Stage I Bladder Cancer | Stage 0a Bladder Urothelial Carcinoma | Stage 0is Bladder Urothelial CarcinomaUnited States
-
St George's, University of LondonUniversity of British Columbia; Bill and Melinda Gates Foundation; Wellcome Trust and other collaboratorsCompletedBacterial InfectionsUnited Kingdom
-
Urological Oncology Council of Northern TokyoUnknown
-
Azienda Ospedaliera "Sant'Andrea"UnknownBladder Cancer
-
Carman GiacomantonioNova Scotia Health AuthorityWithdrawnCutaneous Metastatic Melanoma
-
Nottingham University Hospitals NHS TrustUniversity of Sydney; Australian and New Zealand Urogenital and Prostate Cancer...Active, not recruitingTransitional Cell Carcinoma | Transurethral ResectionUnited Kingdom
-
Swiss Group for Clinical Cancer ResearchRecruitingBladder CancerSwitzerland
-
Ludwig Institute for Cancer ResearchBristol-Myers SquibbTerminatedMetastatic MelanomaAustralia
-
GlaxoSmithKlineThe PATH Malaria Vaccine Initiative (MVI)Completed
-
University of Rome Tor VergataUniversity of L'AquilaCompleted
-
Noah Hahn, M.D.AstraZeneca; Hoosier Cancer Research NetworkRecruitingBladder Cancer | Urothelial CarcinomaUnited States
-
Guangzhou Wondfo Biotech Co., LtdNova Clinical Solutions, Inc.CompletedPregnancyUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Adult Acute Myeloid Leukemia in Remission | Adult Acute Lymphoblastic Leukemia in Remission | Refractory Anemia With Excess Blasts | Refractory... and other conditionsUnited States
-
Julio RamirezUniversity of LouisvilleTerminatedOsteomyelitisUnited States